EQT Exits Aldevron at $9.6 Billion
EQT Private Equity has agreed to sell Aldevron, a producer of nucleic acids and proteins, to Danaher Corporation for $9.6 billion. EQT acquired a majority stake in Aldevron in July 2019 from TA Associates. Aldevron’s